Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03111875
Other study ID # 16-1017
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 27, 2017
Est. completion date May 17, 2022

Study information

Verified date July 2023
Source The Cleveland Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

We propose to test the hypothesis that aggressive warming reduces the incidence of major cardiovascular complications, compared to routine care. Half of the participants will be randomly assigned to routine care (core temperature ≈35.5°C), while the other half will receive aggressive warming (>37°C core temperature) in a multi-center trial.


Description:

Hypothermia increases sympathetic activation, promotes tachycardia, and causes hypertension - all of which may increase the risk of myocardial injury. Moderate perioperative hypothermia is now uncommon, but mild hyperthermia (≈35.5°C) remains common. Whether aggressive warming to a truly normothermic level (≈37°C) improves outcomes remains unknown.


Recruitment information / eligibility

Status Completed
Enrollment 5056
Est. completion date May 17, 2022
Est. primary completion date March 16, 2021
Accepts healthy volunteers No
Gender All
Age group 45 Years and older
Eligibility Inclusion Criteria: - Scheduled for major noncardiac surgery expected to last 2-6 hours; - Having general anesthesia; - Expected to require at least overnight hospitalization; - Expected to have >50% of the anterior skin surface available for warming; - Have at least one of the following risk factors: a. Age over 65 years; b. History of peripheral vascular surgery; c. History of coronary artery disease; d. History of stroke or transient ischemic attack; e. Serum creatinine >175 µmal/L (>2.0 mg/dl); f. Diabetes requiring medication; e. Hypertension requiring medication; g. Current smoking. Exclusion Criteria: - Have a clinically important coagulopathy in the judgement of the attending anesthesiologist; - Are septic (clinical diagnosis by the attending anesthesiologist); - Body mass index exceeding 30 kg/m2; - End-stage renal disease requiring dialysis; - Surgeon believes patient to be at particular infection risk.

Study Design


Intervention

Device:
aggressive warming
Patients will be pre-warming 30 minutes before induction of anesthesia and aggressively warmed during surgery to a target intraoperative core temperature between 37 and 37.5°C.
routine thermal management
A forced-air cover will be positioned but will not initially be activated. The warmer will be activated when core temperature decrease to 35.5°C.

Locations

Country Name City State
China PUMCH Beijing
China West China Hospital Sichuan Univeristy Chengdu
China Guangdong General Hospital Guangzhou
China Chinese University of Hong Kong Hong Kong
China Queen Mary Hospital Hong Kong
China Nanjing Drum Tower Hospital Nanjing
China FDSCC (Fudan University Shanghai Shanghai
China Shanghai Chest Hospital Shanghai
China Shanghai Oriental Hospital Shanghai
China Shanghai Zhongshan Hospital Shanghai
United States Cleveland Clinic Foundation Cleveland Ohio

Sponsors (1)

Lead Sponsor Collaborator
The Cleveland Clinic

Countries where clinical trial is conducted

United States,  China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants With a Composite Outcome Consisted of Myocardial Injury After Non-cardiac Surgery (MINS), Non-fatal Cardiac Arrest, and All-cause Mortality The primary outcome was a composite of myocardial injury after non-cardiac surgery, non-fatal cardiac arrest, and all-cause mortality within 30 days of surgery. Myocardial injury was diagnosed when available troponin concentrations exceeded generation-specific and type-specific thresholds and were apparently of ischaemic origin (ie, no other obvious cause for artifactual elevation). We used the following thresholds based on available literature at time of adjudication: 1) non-high-sensitivity (fourth-generation) troponin T =0.03 ng/ml2; 2) high-sensitivity troponin T =65 ng/L; or high-sensitivity troponin T 20-64 ng/L and an increase =5 ng/L from baseline3; 3) high-sensitivity troponin I (Abbott assay) is =75 ng/L4; 4) high-sensitivity troponin I (Siemens assay) is
=60 ng/L5; or, 5) troponin I (other assays) greater than local 99th percentiles. Myocardial infarction diagnosis required both troponin elevation and at least one diagnostic symptom or sign.
From the end of surgery to 30 days after surgery
Secondary Deep or Organ-space Surgical Site Infection Surgical site infection is defined by US Centers for Disease Control and Prevention criteria. It is consisted of superficial infection, deep infection, and organ-space infection.
Superficial infection: Infection involves only skin or subcutaneous tissue of the incision.
Deep infection: Infection appears to be related to the operation and infection involves deep soft tissues (e.g., fascial and muscle layers) of the incision.
Organ-space infection: Infection involves any part of the anatomy (e.g., organs or spaces), other than the incision, which was opened or manipulated during an operation.
From the end of surgery to 30 days after surgery
Secondary Number of Patients Requiring Intraoperative Transfusion intraoperative transfusion will be yes if this patient received more than 0 unit of red blood cells. From surgery start to surgery end
Secondary Duration of Hospitalization The length of hospital stay in days, censored at 30 days From the day of surgery to the day of discharge, or 30 days after surgery if the patients is still hospitalized
Secondary Readmission Readmission to a hospital within a month of surgery From the end of surgery to 30 days after surgery
See also
  Status Clinical Trial Phase
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT03930784 - A Real-world Study to Examine the Relationship Between Simple Physical Functioning Tests, Complications and Recovery Following Abdominal Surgery.
Not yet recruiting NCT04430972 - Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure)
Recruiting NCT04887415 - Respiratory Strength Training in Cardiac Surgical Patients N/A
Recruiting NCT05254262 - Multicenter National Trial of Clinical Results of Surgical Elderly Patients
Recruiting NCT03561376 - Zinc Oxide Versus Petrolatum Following Skin Surgery Early Phase 1
Recruiting NCT05155878 - Prognostic Factors in Periampullary Tumors and Cysts
Recruiting NCT04967391 - Tumescence in HNC Skin Graft Reconstruction Phase 3
Terminated NCT03757455 - ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy N/A
Completed NCT03793816 - Tonsillectomy Using BiZact™ - a Randomized Side-controlled Clinical Trial N/A
Completed NCT03246165 - Predictive Factors and Complications of Delirium
Withdrawn NCT04090918 - Novel Methods for Characterizing Patients With Post-operative Atrial Fibrillation Secondary to Abdominal Surgery
Completed NCT05373238 - Same Day Discharge After Laparoscopic Hysterectomy
Completed NCT03938584 - The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients N/A
Not yet recruiting NCT05046925 - PACU for Postoperative Care After Major Thoracic and Abdominal Surgery
Completed NCT04550156 - Evaluation of the Introduction of a Colorectal Bundle in Left Sided Colorectal Resections N/A
Not yet recruiting NCT04199208 - Does Prehabilitation Improve Outcome in Coloncancer Surgery? N/A
Completed NCT04257344 - Use of Wearables for Early Detection of Complications After Major Acute Abdominal Surgery
Active, not recruiting NCT03721471 - Outcome of Very Old Patients Admitted for Elective Major Surgery, the Effect of Frailty